Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims.
We report on 5-HT1A, 5-HT1D, and 5-HT2 binding sites in 23 control subjects and 18 suicide victims subdivided according to the method of death and the previous existence of depressive symptoms. No difference in maximum binding (Bmax) or binding affinity (Kd) was found between the control and overall suicide groups for the binding sites studied. The drug overdose subgroup showed, however, a significant decrease in the 5-HT1A binding affinity, probably explained by the higher sensitivity of this binding site to the acute administration of tricyclic antidepressants. A significant decrease in 5-HT1D binding affinity was also found in the depressed suicides, together with a significant decrease in the number of 5-HT1D binding sites in the nondepressed suicides. Further studies should be carried out on the 5-HT1D binding site as it might represent a new tool in the understanding of the depressive illness.
Arranz
B
B
Department of Geriatric Medicine, University of Linköping, Sweden.
Eriksson
A
A
Mellerup
E
E
Plenge
P
P
Marcusson
J
J
D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001921:Brain / Q000033:anatomy & histology / Q000378:metabolism*; D003866:Depressive Disorder / Q000378:metabolism*; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism; D006801:Humans; D007650:Ketanserin / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009929:Organ Size; D011985:Receptors, Serotonin / Q000235:genetics / Q000378:metabolism*; D013405:Suicide / Q000706:statistics & numerical data*
D011985:Receptors, Serotonin; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D007650:Ketanserin